187 related articles for article (PubMed ID: 19357297)
1. Preventing recurrent venous thromboembolism.
Drug Ther Bull; 2009 Apr; 47(4):38-40. PubMed ID: 19357297
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
3. First episode and recurrent venous thromboembolism: who is identifiably at risk?
Liem TK; Deloughery TG
Semin Vasc Surg; 2008 Sep; 21(3):132-8. PubMed ID: 18774448
[TBL] [Abstract][Full Text] [Related]
4. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
Couturaud F; Kearon C
Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
[TBL] [Abstract][Full Text] [Related]
5. D-dimer before chemotherapy might predict venous thromboembolism.
Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
[TBL] [Abstract][Full Text] [Related]
6. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
7. Impact and clinical significance of recurrent venous thromboembolism.
Labropoulos N; Spentzouris G; Gasparis AP; Meissner M
Br J Surg; 2010 Jul; 97(7):989-99. PubMed ID: 20632262
[TBL] [Abstract][Full Text] [Related]
8. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
9. Duration of anticoagulant therapy for patients with venous thromboembolism.
Garcia D
Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
[TBL] [Abstract][Full Text] [Related]
10. [Anticoagulant therapy in venous thromboembolism].
Beyer J; Schellong S
Herz; 2008 Feb; 33(1):52-8. PubMed ID: 18273578
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism: a chronic illness.
Mason C
J Cardiovasc Nurs; 2009; 24(6 Suppl):S4-7. PubMed ID: 19858962
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
13. [Secondary prevention of venous thromboembolism].
Bauersachs RM
Dtsch Med Wochenschr; 2012 Oct; 137(40):1994-7. PubMed ID: 23023608
[No Abstract] [Full Text] [Related]
14. Clinical scores to predict recurrence risk of venous thromboembolism.
Kyrle PA; Eichinger S
Thromb Haemost; 2012 Dec; 108(6):1061-4. PubMed ID: 22872143
[TBL] [Abstract][Full Text] [Related]
15. D-dimer testing to determine the duration of anticoagulant therapy.
Palareti G; Cosmi B; Legnani C
Curr Opin Pulm Med; 2007 Sep; 13(5):393-7. PubMed ID: 17940483
[TBL] [Abstract][Full Text] [Related]
16. [D-dimer dosage for the prediction of recurrent venous thromboembolism].
Guanella R; Righini M; Perrier A
Rev Med Suisse; 2007 Oct; 3(129):2335-8. PubMed ID: 18018824
[TBL] [Abstract][Full Text] [Related]
17. Tests of fibrin metabolism in recurrent venous thromboembolism.
Bynum LJ; Parkey RW; Wilson JE
Arch Intern Med; 1977 Oct; 137(10):1385-9. PubMed ID: 921420
[TBL] [Abstract][Full Text] [Related]
18. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic venous thromboembolic disease. risk factors for recurrence in 2006].
Christiaens L
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):133-8. PubMed ID: 17474499
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of venous thromboembolism in long-term care: identifying and managing the risk.
Haas S; Spyropoulos AC
Clin Appl Thromb Hemost; 2008 Apr; 14(2):149-58. PubMed ID: 18372276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
